Evidence map›Paper›PMID 27090787›Full record

ArticleBMC infectious diseases2016

High prevalence of multidrug resistant Enterobacteriaceae isolated from outpatient urine samples but not the hospital environment in Bo, Sierra Leone.

Tomasz A Leski, Chris R Taitt, Umaru Bangura, Michael G Stockelman, Rashid Ansumana, William H Cooper, David A Stenger, Gary J Vora

Abstract read
In one paragraph

Article in BMC infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Evolution of copper coupons resistance inPakistan journal of medical sciences · 2024
    Article
  8. Article
  9. Article
  10. The Antimicrobial Resistance (AMR) Rates ofAntibiotics (Basel, Switzerland) · 2023
    Article
  11. Novel Starter StrainFoods (Basel, Switzerland) · 2023
    Article
  12. Article
  13. Article
  14. A brief insight intoFrontiers in antibiotics · 2023
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tomasz A LeskiNaval Research Laboratory, Code 6910, 4555 Overlook Avenue SW, Washington, DC, 20375, USA. tomasz.leski@nrl.navy.mil.
Chris R TaittNaval Research Laboratory, Code 6910, 4555 Overlook Avenue SW, Washington, DC, 20375, USA.
Umaru BanguraMercy Hospital Research Laboratory, Bo, Sierra Leone.
Michael G StockelmanNaval Research Laboratory, Code 6910, 4555 Overlook Avenue SW, Washington, DC, 20375, USA.
Rashid AnsumanaMercy Hospital Research Laboratory, Bo, Sierra Leone.
William H CooperBowie State University, Bowie, Maryland, USA.
David A StengerNaval Research Laboratory, Code 6910, 4555 Overlook Avenue SW, Washington, DC, 20375, USA.
Gary J VoraNaval Research Laboratory, Code 6910, 4555 Overlook Avenue SW, Washington, DC, 20375, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe rising level of antimicrobial resistance among bacterial pathogens is one of the most significant public health problems globally. While the antibiotic resistance of clinically important bacteria is closely tracked in many developed countries, the types and levels of resistance and multidrug resistance (MDR) among pathogens currently circulating in most countries of sub-Saharan Africa are virtually unknown.

methodsFrom December 2013 to April 2014, we collected 93 urine specimens from all outpatients showing symptoms of urinary tract infection (UTI) and 189 fomite swabs from a small hospital in Bo, Sierra Leone. Culture on chromogenic agar combined with biochemical and DNA sequence-based assays was used to detect and identify the bacterial isolates. Their antimicrobial susceptibilities were determined using a panel of 11 antibiotics or antibiotic combinations.

resultsThe 70 Enterobacteriaceae urine isolates were identified as Citrobacter freundii (n = 22), Klebsiella pneumoniae (n = 15), Enterobacter cloacae (n = 15), Escherichia coli (n = 13), Enterobacter sp./Leclercia sp. (n = 4) and Escherichia hermannii (n = 1). Antimicrobial susceptibility testing demonstrated that 85.7 % of these isolates were MDR while 64.3 % produced an extended-spectrum ß-lactamase (ESBL). The most notable observations included widespread resistance to sulphonamides (91.4 %), chloramphenicol (72.9 %), gentamycin (72.9 %), ampicillin with sulbactam (51.4 %) and ciprofloxacin (47.1 %) with C. freundii exhibiting the highest and E. coli the lowest prevalence of multidrug resistance. The environmental cultures resulted in only five Enterobacteriaceae isolates out of 189 collected with lower overall antibiotic resistance.

conclusionsThe surprisingly high proportion of C. freundii found in urine of patients with suspected UTI supports earlier findings of the growing role of this pathogen in UTIs in low-resource countries. The isolates of all analyzed species showed worryingly high levels of resistance to both first- and second-line antibiotics as well as a high frequency of MDR and ESBL phenotypes, which likely resulted from the lack of consistent antibiotic stewardship policies in Sierra Leone. Analysis of hospital environmental isolates however suggested that fomites in this naturally ventilated hospital were not a major reservoir for Enterobacteriaceae or antibiotic resistance determinants.

Indexed as

AdultAnti-Bacterial Agentsbeta-LactamasesDNA, BacterialDrug Resistance, Multiple, BacterialEnterobacteriaceaeFemaleHumansMaleMicrobial Sensitivity TestsMiddle AgedOutpatientsSequence Analysis, DNASierra LeoneUrinary Tract InfectionsAnti-Bacterial Agentsbeta-LactamasesDNA, BacterialCHROMagarCitrobacterESBLMDRSierra Leone

Identifiers

PMID27090787
PMCPMC4836052

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.